Shen Yuan Yi Qi Huo Xue capsules inhibit neutrophil NETosis by regulating the PAD4/NLRP3 signaling pathway to prevent heart failure after myocardial infarction
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Yan-Jie Lian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China; Guang'anmen Hospital of the Chinese Academy o…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Myocardial Infarction, Heart Failure, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Science and Technology Planning Project, Beijing Municipal Education Commission, National Natural Science Foundation of China.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Heart failure (HF) is a severe, end-stage condition resulting from various cardiac diseases, with ischemic heart failure (IHF) being a common etiology caused by ischemia. Shen Yuan Yi Qi Huo Xue Capsules (SYYQ) is a traditional Chinese medicine (TCM) formulation known for its anti-thrombotic and myocardial protective effects. Nonetheless, experimental evidence and mechanistic insights into its role in preventing IHF remain limited. PURPOSE: To investigate whether SYYQ reduces post-myocardial infarction (MI) inflammation and cardiac remodeling by inhibiting NETosis and reducing neutrophil activation. METHODS: C57/B6J mice were randomly divided into Sham group, Model group, SYYQ-l, SYYQ-M, SYYQ-H, and Captopril group. MI model was induced by left anterior descending coronary artery ligation in Model group, while Sham group underwent sham surgery. Active compounds in SYYQ were identified using UPLCHRMS. Cardiac function and morphology were assessed using echocardiography, HE staining, Masson's trichrome. ELISA was used to measure myocardial injury markers and inflammatory cytokine expression. Whole blood cell counts assessed neutrophil variations. The mechanism of action of SYYQ was evaluated using Western blot and qPCR, and immunofluorescence. Meanwhile, the PAD4-/- MI mouse Model was constructed and randomly divided into the model group and the SYYQ group. The effect of SYYQ on the expression of key proteins in the occurrence of NETosis was further evaluated by Western blot. The effect of SYYQ was further verified through in vitro experiments. RESULTS: The present study demonstrated that SYYQ improves cardiac function, myocardial microcirculation, and serum myocardial injury markers in MI mice. It reduces inflammatory cell infiltration in damaged myocardial tissue and normalizes elevated levels of NETosis by decreasing neutrophil entry into circulation. Western blot and qPCR results showed that SYYQ inhibits key proteins associated with NETosis including PAD4, NLRP3, Caspase-1, and gasdermin D (GSDMD). Importantly, SYYQ may target PAD4 to inhibit NETosis by suppressing PAD4 and downstream NLRP3, Caspase-1, and GSDMD protein expression levels in neutrophils. CONCLUSION: SYYQ may inhibit neutrophil NETosis after MI, thereby preventing the massive entry of neutrophils into circulation, reducing post-MI inflammation and cardiac remodeling, and improving heart function simultaneously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China; Guang'anmen Hospital of the Chinese Academy of Traditional Chinese Medicine, Beijing 100053, PR China.
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China.
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China; Inner Mongolia Hospital Beijing Hospital Of Traditional Chinese Medicine, Inner Mongolia 015000, PR China. Electron…
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China; Beijing Institute of Traditional Chinese Medicine, Beijing 10010, PR China. Electronic address: lsn710@sina.com.
Förderung
- Beijing Science and Technology Planning Project
- Beijing Municipal Education Commission
- National Natural Science Foundation of China
Zitieren
APA
Lian, Y. J., Zhang, H. Y., Liu, H. X., Shang, J. J., Lai, X. L., Xing, W. L., & Li, S. N. (2025). Shen Yuan Yi Qi Huo Xue capsules inhibit neutrophil NETosis by regulating the PAD4/NLRP3 signaling pathway to prevent heart failure after myocardial infarction. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157462
Vancouver
Lian YJ, Zhang HY, Liu HX, Shang JJ, Lai XL, Xing WL, et al. Shen Yuan Yi Qi Huo Xue capsules inhibit neutrophil NETosis by regulating the PAD4/NLRP3 signaling pathway to prevent heart failure after myocardial infarction. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157462
BibTeX
@article{Lian2025,
author = {Lian, Yan-Jie and Zhang, He-Yi and Liu, Hong-Xu and Shang, Ju-Ju and Lai, Xiao-Lei and Xing, Wen-Long and Li, Si-Nai},
title = {Shen Yuan Yi Qi Huo Xue capsules inhibit neutrophil NETosis by regulating the PAD4/NLRP3 signaling pathway to prevent heart failure after myocardial infarction},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157462}
}
EUVIMED